Last 12 months
Inside the activity.
0 purchase rows · 35 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 8 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 16 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2020 Filed Jun 3, 2020 01:15 UTC |
Parrish JayChief Business Officer
|
SaleCommon Stock | 75,000 | $35.22 | $2,641,410.00 |
DisclosureSEC source: 0001209191-20-033780 · doc4.xml · nonDerivative · entry 2 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,222 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.2144 to $35.2245, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 01:15 UTC |
Parrish JayChief Business Officer
|
Exercise / conversionCommon Stock | 75,000 | $1.49 | $111,375.00 |
DisclosureSEC source: 0001209191-20-033780 · doc4.xml · nonDerivative · entry 1 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,222 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 01:14 UTC |
Horn HowardCFO
|
SaleCommon Stock | 6,714 | $35.38 | $237,572.88 |
DisclosureSEC source: 0001209191-20-033779 · doc4.xml · nonDerivative · entry 2 Horn Howard · CIK 0001786335 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,777 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 01:14 UTC |
Horn HowardCFO
|
SaleCommon Stock | 3,286 | $34.53 | $113,465.25 |
DisclosureSEC source: 0001209191-20-033779 · doc4.xml · nonDerivative · entry 1 Horn Howard · CIK 0001786335 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,491 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| May 26, 2020 Filed May 27, 2020 21:00 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,805 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-20-032330 · doc4.xml · derivative · entry 3 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 546,190 Underlying: Common Stock · 3,805 shares Expires 2028-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| May 26, 2020 Filed May 27, 2020 21:00 UTC |
Virgin HerbertEVP, Research & CSO
|
SaleCommon Stock | 3,805 | $34.08 | $129,674.40 |
DisclosureSEC source: 0001209191-20-032330 · doc4.xml · nonDerivative · entry 2 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| May 26, 2020 Filed May 27, 2020 21:00 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionCommon Stock | 3,805 | $1.53 | $5,821.65 |
DisclosureSEC source: 0001209191-20-032330 · doc4.xml · nonDerivative · entry 1 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,805 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2020 Filed May 26, 2020 21:00 UTC |
SHARP PHILLIP ADirector
|
GrantStock Option (Right to Buy) · Derivative | 28,888 | $0.00 Strike: $37.06 | $0.00 |
DisclosureSEC source: 0001209191-20-032066 · doc4.xml · derivative · entry 1 SHARP PHILLIP A · CIK 0001226295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,888 Underlying: Common Stock · 28,888 shares Expires 2030-05-21 Read SEC document |
| May 21, 2020 Filed May 26, 2020 21:00 UTC |
MORE ROBERT JDirector
|
GrantStock Option (Right to Buy) · Derivative | 28,888 | $0.00 Strike: $37.06 | $0.00 |
DisclosureSEC source: 0001209191-20-032065 · doc4.xml · derivative · entry 1 MORE ROBERT J · CIK 0001207792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,888 Underlying: Common Stock · 28,888 shares Expires 2030-05-21 Read SEC document |
| May 21, 2020 Filed May 26, 2020 21:00 UTC |
NELSEN ROBERTDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 28,888 | $0.00 Strike: $37.06 | $0.00 |
DisclosureSEC source: 0001209191-20-032064 · doc4.xml · derivative · entry 1 NELSEN ROBERT · CIK 0001219042 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,888 Underlying: Common Stock · 28,888 shares Expires 2030-05-21 Read SEC document |
| May 21, 2020 Filed May 26, 2020 21:00 UTC |
Burow KristinaDirector
|
GrantStock Option (Right to Buy) · Derivative | 28,888 | $0.00 Strike: $37.06 | $0.00 |
DisclosureSEC source: 0001209191-20-032063 · doc4.xml · derivative · entry 1 Burow Kristina · CIK 0001569248 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,888 Underlying: Common Stock · 28,888 shares Expires 2030-05-21 Read SEC document |
| May 21, 2020 Filed May 26, 2020 21:00 UTC |
Ramasastry SairaDirector
|
GrantStock Option (Right to Buy) · Derivative | 28,888 | $0.00 Strike: $37.06 | $0.00 |
DisclosureSEC source: 0001209191-20-032062 · doc4.xml · derivative · entry 1 Ramasastry Saira · CIK 0001547959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,888 Underlying: Common Stock · 28,888 shares Expires 2030-05-21 Read SEC document |
| May 21, 2020 Filed May 26, 2020 21:00 UTC |
Nishar DipchandDirector
|
GrantStock Option (Right to Buy) · Derivative | 28,888 | $0.00 Strike: $37.06 | $0.00 |
DisclosureSEC source: 0001209191-20-032061 · doc4.xml · derivative · entry 1 Nishar Dipchand · CIK 0001519500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,888 Underlying: Common Stock · 28,888 shares Expires 2030-05-21 Read SEC document |
| May 21, 2020 Filed May 26, 2020 21:00 UTC |
PEREZ ROBERT JDirector
|
GrantStock Option (Right to Buy) · Derivative | 28,888 | $0.00 Strike: $37.06 | $0.00 |
DisclosureSEC source: 0001209191-20-032060 · doc4.xml · derivative · entry 1 PEREZ ROBERT J · CIK 0001263230 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,888 Underlying: Common Stock · 28,888 shares Expires 2030-05-21 Read SEC document |
| May 21, 2020 Filed May 26, 2020 21:00 UTC |
SATO VICKI LDirector
|
GrantStock Option (Right to Buy) · Derivative | 28,888 | $0.00 Strike: $37.06 | $0.00 |
DisclosureSEC source: 0001209191-20-032059 · doc4.xml · derivative · entry 1 SATO VICKI L · CIK 0001197020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,888 Underlying: Common Stock · 28,888 shares Expires 2030-05-21 Read SEC document |
| May 21, 2020 Filed Oct 13, 2020 23:15 UTC Amendment |
SHARP PHILLIP ADirector
|
GrantStock Option (Right to Buy) · Derivative | 24,850 | $0.00 Strike: $37.06 | $0.00 |
DisclosureSEC source: 0001209191-20-054742 · doc4a.xml · derivative · entry 1 SHARP PHILLIP A · CIK 0001226295 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,850 Underlying: Common Stock · 24,850 shares Expires 2030-05-20 Read SEC document |
| May 21, 2020 Filed Oct 13, 2020 23:14 UTC Amendment |
SATO VICKI LDirector
|
GrantStock Option (Right to Buy) · Derivative | 23,649 | $0.00 Strike: $37.06 | $0.00 |
DisclosureSEC source: 0001209191-20-054741 · doc4a.xml · derivative · entry 1 SATO VICKI L · CIK 0001197020 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,649 Underlying: Common Stock · 23,649 shares Expires 2030-05-20 Read SEC document |
| May 21, 2020 Filed Oct 13, 2020 23:13 UTC Amendment |
Ramasastry SairaDirector
|
GrantStock Option (Right to Buy) · Derivative | 24,497 | $0.00 Strike: $37.06 | $0.00 |
DisclosureSEC source: 0001209191-20-054740 · doc4a.xml · derivative · entry 1 Ramasastry Saira · CIK 0001547959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,497 Underlying: Common Stock · 24,497 shares Expires 2030-05-20 Read SEC document |
| May 21, 2020 Filed Oct 13, 2020 23:11 UTC Amendment |
Nishar DipchandDirector
|
GrantStock Option (Right to Buy) · Derivative | 24,885 | $0.00 Strike: $37.06 | $0.00 |
DisclosureSEC source: 0001209191-20-054738 · doc4a.xml · derivative · entry 1 Nishar Dipchand · CIK 0001519500 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,885 Underlying: Common Stock · 24,885 shares Expires 2030-05-20 Read SEC document |
| May 21, 2020 Filed Oct 13, 2020 23:12 UTC Amendment |
PEREZ ROBERT JDirector
|
GrantStock Option (Right to Buy) · Derivative | 24,567 | $0.00 Strike: $37.06 | $0.00 |
DisclosureSEC source: 0001209191-20-054739 · doc4a.xml · derivative · entry 1 PEREZ ROBERT J · CIK 0001263230 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,567 Underlying: Common Stock · 24,567 shares Expires 2030-05-20 Read SEC document |
| May 21, 2020 Filed Oct 13, 2020 23:11 UTC Amendment |
MORE ROBERT JDirector
|
GrantStock Option (Right to Buy) · Derivative | 24,355 | $0.00 Strike: $37.06 | $0.00 |
DisclosureSEC source: 0001209191-20-054737 · doc4a.xml · derivative · entry 1 MORE ROBERT J · CIK 0001207792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,355 Underlying: Common Stock · 24,355 shares Expires 2030-05-20 Read SEC document |
| May 21, 2020 Filed Oct 13, 2020 23:09 UTC Amendment |
NELSEN ROBERTDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 24,885 | $0.00 Strike: $37.06 | $0.00 |
DisclosureSEC source: 0001209191-20-054736 · doc4a.xml · derivative · entry 1 NELSEN ROBERT · CIK 0001219042 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,885 Underlying: Common Stock · 24,885 shares Expires 2030-05-20 Read SEC document |
| May 21, 2020 Filed Oct 13, 2020 23:08 UTC Amendment |
Burow KristinaDirector
|
GrantStock Option (Right to Buy) · Derivative | 25,404 | $0.00 Strike: $37.06 | $0.00 |
DisclosureSEC source: 0001209191-20-054735 · doc4a.xml · derivative · entry 1 Burow Kristina · CIK 0001569248 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,404 Underlying: Common Stock · 25,404 shares Expires 2030-05-20 Read SEC document |
| May 18, 2020 Filed May 19, 2020 21:21 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,755 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-20-030596 · doc4.xml · derivative · entry 3 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 549,995 Underlying: Common Stock · 1,755 shares Expires 2028-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| May 18, 2020 Filed May 19, 2020 21:21 UTC |
Virgin HerbertEVP, Research & CSO
|
SaleCommon Stock | 1,755 | $38.00 | $66,690.00 |
DisclosureSEC source: 0001209191-20-030596 · doc4.xml · nonDerivative · entry 2 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. Read SEC document |
| May 18, 2020 Filed May 19, 2020 21:21 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionCommon Stock | 1,755 | $1.53 | $2,685.15 |
DisclosureSEC source: 0001209191-20-030596 · doc4.xml · nonDerivative · entry 1 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,755 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 14, 2020 Filed May 15, 2020 23:48 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 3,805 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-20-029879 · doc4.xml · derivative · entry 3 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 551,750 Underlying: Common Stock · 3,805 shares Expires 2028-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on January 8, 2019, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| May 14, 2020 Filed May 15, 2020 23:48 UTC |
Virgin HerbertEVP, Research & CSO
|
SaleCommon Stock | 3,805 | $30.07 | $114,418.25 |
DisclosureSEC source: 0001209191-20-029879 · doc4.xml · nonDerivative · entry 2 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.0549 to $30.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| May 14, 2020 Filed May 15, 2020 23:48 UTC |
Virgin HerbertEVP, Research & CSO
|
Exercise / conversionCommon Stock | 3,805 | $1.53 | $5,821.65 |
DisclosureSEC source: 0001209191-20-029879 · doc4.xml · nonDerivative · entry 1 Virgin Herbert · CIK 0001786378 · EVP, Research & CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,805 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 14, 2020 Filed May 15, 2020 23:18 UTC |
Parrish JayChief Business Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $1.49 | $0.00 |
DisclosureSEC source: 0001209191-20-029859 · doc4.xml · derivative · entry 3 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,221 Underlying: Common Stock · 75,000 shares Expires 2027-10-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/4 of the shares subject to the stock option vested and became exercisable on April 3, 2018, and the remaining shares vest in 36 equal monthly installments thereafter. Read SEC document |
| May 14, 2020 Filed May 15, 2020 23:18 UTC |
Parrish JayChief Business Officer
|
SaleCommon Stock | 75,000 | $30.05 | $2,253,885.00 |
DisclosureSEC source: 0001209191-20-029859 · doc4.xml · nonDerivative · entry 2 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,222 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.0002 to $30.1521, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| May 14, 2020 Filed May 15, 2020 23:18 UTC |
Parrish JayChief Business Officer
|
Exercise / conversionCommon Stock | 75,000 | $1.49 | $111,375.00 |
DisclosureSEC source: 0001209191-20-029859 · doc4.xml · nonDerivative · entry 1 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,222 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2020 Filed May 5, 2020 21:55 UTC |
MORE ROBERT JDirector
|
SaleCommon Stock | 2,700 | $28.60 | $77,212.44 |
DisclosureSEC source: 0001209191-20-027256 · doc4.xml · nonDerivative · entry 2 MORE ROBERT J · CIK 0001207792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,534 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.51 to $28.675, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. Read SEC document |
| May 01, 2020 Filed May 5, 2020 21:55 UTC |
MORE ROBERT JDirector
|
SaleCommon Stock | 15,758 | $27.90 | $439,640.32 |
DisclosureSEC source: 0001209191-20-027256 · doc4.xml · nonDerivative · entry 1 MORE ROBERT J · CIK 0001207792 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,234 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.51 to $28.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. F2 · balance_after: Includes an estimated 29,170 shares received in a pro-rata distribution from Alta Partners NextGen Fund I, L.P. (APNG 1) initiated on April 29, 2020. The reporting person will file an amendment to this Form 4 if the final number of shares received by him in the distribution changes from the amount reported herein. Read SEC document |
| April 17, 2020 Filed Apr 21, 2020 00:20 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 8,000 | $0.00 Strike: $0.86 | $0.00 |
DisclosureSEC source: 0001209191-20-025177 · doc4.xml · derivative · entry 2 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,333 Underlying: Common Stock · 8,000 shares Expires 2027-03-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 1/4 of the 111,111 shares originally subject to the stock option vested and became exercisable on December 14, 2017, and the remaining shares vest in 36 equal monthly installments thereafter. The aggregate number of shares subject to the stock option has been reduced by one share to 111,110 shares due to rounding in connection with a partial exercise of the stock option and a reverse stock split effected prior to the Issuer's initial public offering. Read SEC document |
| April 17, 2020 Filed Apr 21, 2020 00:20 UTC |
Pang PhillipChief Medical Officer
|
Exercise / conversionCommon Stock | 8,000 | $0.86 | $6,840.00 |
DisclosureSEC source: 0001209191-20-025177 · doc4.xml · nonDerivative · entry 1 Pang Phillip · CIK 0001787370 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,777 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 14, 2020 Filed Apr 16, 2020 21:33 UTC |
SCANGOS GEORGE ADirector · President and CEO
|
OtherCommon Stock | 236,806 | $29.56 | $6,999,985.36 |
DisclosureSEC source: 0001209191-20-024672 · doc4.xml · nonDerivative · entry 2 SCANGOS GEORGE A · CIK 0001202102 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,713,559 F1 · kind: This transaction represents a substitution of assets in which 236,806 shares of the Issuer's common stock were transferred to the reporting person from the George A. Scangos 2018 Annuity Trust dated August 30, 2018 (the "GRAT") in exchange for other assets. The reporting person was the beneficial owner of the shares while they were held by the GRAT and remains the beneficial owner of the shares following their withdrawal from the GRAT. The reporting person believes that the transfer was exempt under Rule 16a-13 under the Securities Exchange Act of 1934. F2 · price: Represents the average of the reported high and low per share prices for the Issuer's common stock on the date of the transaction. F4 · balance_after: The total number of shares of common stock reported herein as directly owned includes 78,087 shares previously reported as indirectly owned through the GRAT and subsequently distributed to the reporting person in accordance with the terms of the GRAT. Read SEC document |
| April 14, 2020 Filed Apr 16, 2020 21:33 UTC |
SCANGOS GEORGE ADirector · President and CEO
|
OtherCommon Stock | 236,806 | $29.56 | $6,999,985.36 |
DisclosureSEC source: 0001209191-20-024672 · doc4.xml · nonDerivative · entry 1 SCANGOS GEORGE A · CIK 0001202102 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,907,329 F1 · kind: This transaction represents a substitution of assets in which 236,806 shares of the Issuer's common stock were transferred to the reporting person from the George A. Scangos 2018 Annuity Trust dated August 30, 2018 (the "GRAT") in exchange for other assets. The reporting person was the beneficial owner of the shares while they were held by the GRAT and remains the beneficial owner of the shares following their withdrawal from the GRAT. The reporting person believes that the transfer was exempt under Rule 16a-13 under the Securities Exchange Act of 1934. F2 · price: Represents the average of the reported high and low per share prices for the Issuer's common stock on the date of the transaction. F3 · ownership.nature: The shares are held in the name of the GRAT, of which the reporting person and his spouse are trustees. Read SEC document |
| April 03, 2020 Filed Feb 12, 2021 22:00 UTC |
Parrish JayChief Business Officer
|
GiftCommon Stock | 106,481 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-010195 · doc5.xml · nonDerivative · entry 2 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,260 F2 · kind: Gift by the Reporting Person for estate planning purposes to an irrevocable trust which is managed by an independent trustee. The Reporting Person holds no voting or dispositive power over the securities held by the trust. Read SEC document |
| April 03, 2020 Filed Feb 12, 2021 22:00 UTC |
Parrish JayChief Business Officer
|
GiftCommon Stock | 106,481 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-010195 · doc5.xml · nonDerivative · entry 1 Parrish Jay · CIK 0001786372 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,741 F1 · kind: Gift by the Reporting Person for estate planning purposes to an irrevocable trust which is managed by an independent trustee. The Reporting Person holds no voting or dispositive power over the securities held by the trust. Read SEC document |
| February 25, 2020 Filed Feb 28, 2020 00:56 UTC |
Horn HowardCFO
|
GrantStock Option (Right to Buy) · Derivative | 60,000 | $0.00 Strike: $21.73 | $0.00 |
DisclosureSEC source: 0001209191-20-013608 · doc4.xml · derivative · entry 1 Horn Howard · CIK 0001786335 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2030-02-25 F1 · derivative.exercise_date: 1/4 of the shares subject to the stock option vest and become exercisable on February 25, 2021, and the remainder vest in 36 equal monthly installments thereafter. Read SEC document |
| December 10, 2019 Filed Dec 12, 2019 21:20 UTC |
Ramasastry SairaDirector
|
GrantStock Option (Right to Buy) · Derivative | 57,777 | $0.00 Strike: $12.76 | $0.00 |
DisclosureSEC source: 0001209191-19-060214 · doc4.xml · derivative · entry 1 Ramasastry Saira · CIK 0001547959 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,777 Underlying: Common Stock · 57,777 shares Expires 2029-12-10 F1 · derivative.exercise_date: 1/3 of the shares subject to the stock option vest and become exercisable on September 4, 2020, and the remaining shares vest in 24 equal monthly installments thereafter. Read SEC document |
| October 16, 2019 Filed Oct 16, 2019 20:33 UTC |
Alaska Permanent Fund Corp10% owner
|
ConversionSeries B convertible preferred stock · Derivative | 55,556 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-001253 · form4.xml · derivative · entry 9 Alaska Permanent Fund Corp · CIK 0001582681 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Altitude Life Science Ventures Fund II, L.P. and Altitude Life Science Ventures Side Fund II, L.P Disclosed balance after: 0 Underlying: Common Stock · 55,556 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Upon closing of the issuer's initial public offering, the Series A-1 convertible preferred stock and Series B convertible preferred stock converted automatically into Common Stock on a 1-for-1 basis without payment of further consideration. There was no expiration date for the Series A-1 convertible preferred stock or Series B convertible preferred stock. On September 27, 2019, prior to the closing of the issuer's initial public offering, the issuer effected a 1-for-4.5 reverse stock split of its common stock and convertible preferred stock which is reflected in the numbers above. F1 · derivative.exercise_date: Upon closing of the issuer's initial public offering, the Series A-1 convertible preferred stock and Series B convertible preferred stock converted automatically into Common Stock on a 1-for-1 basis without payment of further consideration. There was no expiration date for the Series A-1 convertible preferred stock or Series B convertible preferred stock. On September 27, 2019, prior to the closing of the issuer's initial public offering, the issuer effected a 1-for-4.5 reverse stock split of its common stock and convertible preferred stock which is reflected in the numbers above. F1 · derivative.expiration_date: Upon closing of the issuer's initial public offering, the Series A-1 convertible preferred stock and Series B convertible preferred stock converted automatically into Common Stock on a 1-for-1 basis without payment of further consideration. There was no expiration date for the Series A-1 convertible preferred stock or Series B convertible preferred stock. On September 27, 2019, prior to the closing of the issuer's initial public offering, the issuer effected a 1-for-4.5 reverse stock split of its common stock and convertible preferred stock which is reflected in the numbers above. Read SEC document |
| October 16, 2019 Filed Oct 16, 2019 20:33 UTC |
Alaska Permanent Fund Corp10% owner
|
ConversionSeries A-1 convertible preferred stock · Derivative | 666,667 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-001253 · form4.xml · derivative · entry 7 Alaska Permanent Fund Corp · CIK 0001582681 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Altitude Life Science Ventures Fund II, L.P. and Altitude Life Science Ventures Side Fund II, L.P Disclosed balance after: 0 Underlying: Common Stock · 666,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Upon closing of the issuer's initial public offering, the Series A-1 convertible preferred stock and Series B convertible preferred stock converted automatically into Common Stock on a 1-for-1 basis without payment of further consideration. There was no expiration date for the Series A-1 convertible preferred stock or Series B convertible preferred stock. On September 27, 2019, prior to the closing of the issuer's initial public offering, the issuer effected a 1-for-4.5 reverse stock split of its common stock and convertible preferred stock which is reflected in the numbers above. F1 · derivative.exercise_date: Upon closing of the issuer's initial public offering, the Series A-1 convertible preferred stock and Series B convertible preferred stock converted automatically into Common Stock on a 1-for-1 basis without payment of further consideration. There was no expiration date for the Series A-1 convertible preferred stock or Series B convertible preferred stock. On September 27, 2019, prior to the closing of the issuer's initial public offering, the issuer effected a 1-for-4.5 reverse stock split of its common stock and convertible preferred stock which is reflected in the numbers above. F1 · derivative.expiration_date: Upon closing of the issuer's initial public offering, the Series A-1 convertible preferred stock and Series B convertible preferred stock converted automatically into Common Stock on a 1-for-1 basis without payment of further consideration. There was no expiration date for the Series A-1 convertible preferred stock or Series B convertible preferred stock. On September 27, 2019, prior to the closing of the issuer's initial public offering, the issuer effected a 1-for-4.5 reverse stock split of its common stock and convertible preferred stock which is reflected in the numbers above. Read SEC document |
| October 16, 2019 Filed Oct 16, 2019 20:33 UTC |
Alaska Permanent Fund Corp10% owner
|
ConversionSeries A-1 convertible preferred stock · Derivative | 2,222,222 | $0.00 | $0.00 |
DisclosureSEC source: 0000898432-19-001253 · form4.xml · derivative · entry 6 Alaska Permanent Fund Corp · CIK 0001582681 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Yukon Investors, LLC Disclosed balance after: 0 Underlying: Common Stock · 2,222,222 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Upon closing of the issuer's initial public offering, the Series A-1 convertible preferred stock and Series B convertible preferred stock converted automatically into Common Stock on a 1-for-1 basis without payment of further consideration. There was no expiration date for the Series A-1 convertible preferred stock or Series B convertible preferred stock. On September 27, 2019, prior to the closing of the issuer's initial public offering, the issuer effected a 1-for-4.5 reverse stock split of its common stock and convertible preferred stock which is reflected in the numbers above. F1 · derivative.exercise_date: Upon closing of the issuer's initial public offering, the Series A-1 convertible preferred stock and Series B convertible preferred stock converted automatically into Common Stock on a 1-for-1 basis without payment of further consideration. There was no expiration date for the Series A-1 convertible preferred stock or Series B convertible preferred stock. On September 27, 2019, prior to the closing of the issuer's initial public offering, the issuer effected a 1-for-4.5 reverse stock split of its common stock and convertible preferred stock which is reflected in the numbers above. F1 · derivative.expiration_date: Upon closing of the issuer's initial public offering, the Series A-1 convertible preferred stock and Series B convertible preferred stock converted automatically into Common Stock on a 1-for-1 basis without payment of further consideration. There was no expiration date for the Series A-1 convertible preferred stock or Series B convertible preferred stock. On September 27, 2019, prior to the closing of the issuer's initial public offering, the issuer effected a 1-for-4.5 reverse stock split of its common stock and convertible preferred stock which is reflected in the numbers above. Read SEC document |
| October 16, 2019 Filed Oct 16, 2019 20:33 UTC |
Alaska Permanent Fund Corp10% owner
|
PurchaseCommon Stock | 1,500,000 | $20.00 | $30,000,000.00 |
DisclosureSEC source: 0000898432-19-001253 · form4.xml · nonDerivative · entry 5 Alaska Permanent Fund Corp · CIK 0001582681 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,555,556 Read SEC document |
| October 16, 2019 Filed Oct 16, 2019 20:33 UTC |
Alaska Permanent Fund Corp10% owner
|
ConversionCommon Stock | 55,556 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-19-001253 · form4.xml · nonDerivative · entry 4 Alaska Permanent Fund Corp · CIK 0001582681 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Altitude Life Science Ventures Fund II, L.P. and Altitude Life Science Ventures Side Fund II, L.P Disclosed balance after: 5,555,556 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Upon closing of the issuer's initial public offering, the Series A-1 convertible preferred stock and Series B convertible preferred stock converted automatically into Common Stock on a 1-for-1 basis without payment of further consideration. There was no expiration date for the Series A-1 convertible preferred stock or Series B convertible preferred stock. On September 27, 2019, prior to the closing of the issuer's initial public offering, the issuer effected a 1-for-4.5 reverse stock split of its common stock and convertible preferred stock which is reflected in the numbers above. Read SEC document |
| October 16, 2019 Filed Oct 16, 2019 20:33 UTC |
Alaska Permanent Fund Corp10% owner
|
ConversionCommon Stock | 1,111,111 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-19-001253 · form4.xml · nonDerivative · entry 3 Alaska Permanent Fund Corp · CIK 0001582681 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Yukon Investors, LLC Disclosed balance after: 5,555,556 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Upon closing of the issuer's initial public offering, the Series A-1 convertible preferred stock and Series B convertible preferred stock converted automatically into Common Stock on a 1-for-1 basis without payment of further consideration. There was no expiration date for the Series A-1 convertible preferred stock or Series B convertible preferred stock. On September 27, 2019, prior to the closing of the issuer's initial public offering, the issuer effected a 1-for-4.5 reverse stock split of its common stock and convertible preferred stock which is reflected in the numbers above. Read SEC document |
| October 16, 2019 Filed Oct 16, 2019 20:33 UTC |
Alaska Permanent Fund Corp10% owner
|
ConversionCommon Stock | 666,667 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-19-001253 · form4.xml · nonDerivative · entry 2 Alaska Permanent Fund Corp · CIK 0001582681 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Altitude Life Science Ventures Fund II, L.P. and Altitude Life Science Ventures Side Fund II, L.P Disclosed balance after: 5,555,556 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Upon closing of the issuer's initial public offering, the Series A-1 convertible preferred stock and Series B convertible preferred stock converted automatically into Common Stock on a 1-for-1 basis without payment of further consideration. There was no expiration date for the Series A-1 convertible preferred stock or Series B convertible preferred stock. On September 27, 2019, prior to the closing of the issuer's initial public offering, the issuer effected a 1-for-4.5 reverse stock split of its common stock and convertible preferred stock which is reflected in the numbers above. Read SEC document |
| October 16, 2019 Filed Oct 16, 2019 20:33 UTC |
Alaska Permanent Fund Corp10% owner
|
ConversionCommon Stock | 2,222,222 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000898432-19-001253 · form4.xml · nonDerivative · entry 1 Alaska Permanent Fund Corp · CIK 0001582681 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Yukon Investors, LLC Disclosed balance after: 5,555,556 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Upon closing of the issuer's initial public offering, the Series A-1 convertible preferred stock and Series B convertible preferred stock converted automatically into Common Stock on a 1-for-1 basis without payment of further consideration. There was no expiration date for the Series A-1 convertible preferred stock or Series B convertible preferred stock. On September 27, 2019, prior to the closing of the issuer's initial public offering, the issuer effected a 1-for-4.5 reverse stock split of its common stock and convertible preferred stock which is reflected in the numbers above. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.